225Ac theranostic pair

N/A

Report date: 2025/11/24 17:31:48

NME

Base Information

Drug Name225Ac theranostic pair

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Radiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225Ac +[4]

Mechanisms of ActionPositron-emission tomography enhancersCalcitonin gene-related peptide receptor antagonists

TargetsCalcitonin gene-related peptide receptor

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFuzionaire Theranostics Inc

China Registration ClassN/A

Develop Information

Active CompaniesFuzionaire Theranostics Inc

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A